Healthcare ❯ Clinical Trials

Phase 3 Trials

Drug Efficacy Efficacy Studies Efficacy and Safety Solid Tumors Obesity Treatments Drug Development Weight Loss Trials Patient Adherence Regulatory Milestones SYNCHRONY Programme TRIUMPH-1 Trial Intervention Studies Checkpoint Inhibitors Treatment Efficacy Focal Onset Seizures

Eli Lilly Rides Breakthrough Retatrutide Data and $4 Billion Vaccine Push to Record Highs

New clinical wins are widening near‑term commercial access, creating cash flow to fund roughly $3.8–4.0 billion of vaccine and delivery acquisitions.

Novo Nordisk Lifts 2026 Outlook as Wegovy Pill Powers Big Q1 Beat

Compass Pathways’ Psilocybin Therapy Hits Phase 3 Goal in Treatment-Resistant Depression

FDA Grants National Priority Voucher to J&J’s Tecvayli–Darzalex Combo in Multiple Myeloma

Terns’ TERN-701 Shows Strong CML Responses in CARDINAL, Setting 320 mg and 500 mg Phase 2 Doses

Weekly Oral Risperidone Pill Maintains Steady Levels in Phase 3 Schizophrenia Trial

Inherited Mitochondrial Variant Linked to Checkpoint Inhibitor Resistance in Metastatic Melanoma